CD8A and neoplasm: Depending on these, LSD1 inhibition can enhance the ability of MSCs to present immunogenic peptides to CD8+T cells by inducing the expression of MHC-I molecules on the surface of MSCs, which induces an effective anti-tumor immune response in consequence 95.